Vera Magistroni
Monza, 20900, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Synergistic Drug Combinations Prevent Resistance in ALK+ Anaplastic Large Cell Lymphoma.
Journal: Cancers
Published: July 13, 2021
De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways.
Journal: Haematologica
Published: January 19, 2018
Erratum: OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes.
Journal: Scientific reports
Published: May 23, 2017
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub.
Journal: Nature communications
Published: December 14, 2016
OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes.
Journal: Scientific reports
Published: July 06, 2016
The Novel PIM1 Inhibitor NMS-P645 Reverses PIM1-Dependent Effects on TMPRSS2/ERG Positive Prostate Cancer Cells And Shows Anti-Proliferative Activity in Combination with PI3K Inhibition.
Journal: Journal of Cancer
Published: April 13, 2016
RNA-seq is a valuable complement of conventional diagnostic tools in newly diagnosed AML patients.
Journal: American journal of hematology
Published: September 25, 2015
BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene.
Journal: Molecular cancer
Published: April 28, 2015
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia.
Journal: Blood
Published: October 26, 2014
Last Updated: 09/26/2026